Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
10.27
-0.51 (-4.73%)
At close: Oct 10, 2025, 4:00 PM EDT
10.10
-0.17 (-1.66%)
After-hours: Oct 10, 2025, 7:49 PM EDT

Tempest Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Selling, General & Admin
13.5813.5511.6612.119.824.91
Upgrade
Research & Development
29.828.4817.522.5317.1714.39
Upgrade
Total Operating Expenses
43.3742.0329.1634.6426.9919.3
Upgrade
Operating Income
-43.37-42.03-29.16-34.64-26.99-19.3
Upgrade
Interest Income
1.061.51.120.55-0.030.09
Upgrade
Interest Expense
-0.78-1.32-1.45-1.62-1.28-
Upgrade
Other Non-Operating Income (Expense)
-0.18-0.33-1.07--
Upgrade
Total Non-Operating Income (Expense)
0.270.37-0.67-2.14-1.320.09
Upgrade
Pretax Income
-43.1-41.66-29.83-36.78-28.3-19.21
Upgrade
Net Income
-43.1-41.84-29.49-35.71-28.3-19.21
Upgrade
Net Income to Common
-43.1-41.84-29.49-35.71-28.3-19.21
Upgrade
Shares Outstanding (Basic)
321100
Upgrade
Shares Outstanding (Diluted)
321100
Upgrade
Shares Change (YoY)
104.83%80.99%33.49%204.70%709.62%-48.77%
Upgrade
EPS (Basic)
-14.59-19.50-24.83-40.17-97.11-533.39
Upgrade
EPS (Diluted)
-14.59-19.50-24.83-40.17-97.11-533.39
Upgrade
Free Cash Flow
-36.8-33.46-27.53-31.63-26.09-19.07
Upgrade
Free Cash Flow Per Share
-11.89-15.59-23.21-35.61-89.49-529.46
Upgrade
EBITDA
-43.09-41.64-28.78-34-26.61-18.96
Upgrade
EBIT
-43.37-42.03-29.16-34.64-26.99-19.3
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q